Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal. Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company,...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal. Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company,...
You must be a Standard 1 Year member to access this content.
Mintz advised Vicarious Surgical Inc. on the deal. Vicarious Surgical Inc., a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures...
You must be a Standard 1 Year member to access this content.
